Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia.

Publication Title

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K

Authors

Jeff P Sharman
Miklos Egyed
Wojciech Jurczak
Alan Skarbnik
John M Pagel, Swedish Cancer Institute, Center for Blood Disorders and Stem Cell Transplantation, Seattle, WA, USAFollow
Ian W Flinn
Manali Kamdar
Talha Munir
Renata Walewska
Gillian Corbett
Laura Maria Fogliatto
Yair Herishanu
Versha Banerji
Steven Coutre
George Follows
Patricia Walker
Karin Karlsson
Paolo Ghia
Ann Janssens
Florence Cymbalista
Jennifer A Woyach
Emmanuelle Ferrant
William G Wierda
Veerendra Munugalavadla
Ting Yu
Min Hui Wang
John C Byrd

Document Type

Article

Publication Date

1-1-2022

Keywords

washington; swedish; seattle

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Specialty/Research Institute

Hematology